Diagnosis of inherited disorders of galactose metabolism.

Galactose metabolism occurs through an evolutionarily conserved pathway in which galactose and uridine diphosphoglucose are converted to glucose-1-phosphate and uridine diphosphogalactose through the action of three sequential enzymes: galactokinase (GALK, EC 2.7.1.6), galactose-1-phosphate uridyltransferase (GALT, EC 2.7.7.12), and uridine phosphogalactose 4'-epimerase (GALE, EC 5.1.3.2). Inborn errors of galactose metabolism occur with impaired activity for each of the enzymes. Classical galactosemia is the most common and the most severe of these diseases and is caused by deficiency of the GALT enzyme, affecting from approximately 1 in 10,000 to 1 in 30,000 live births. Deficiency of GALE is the rarest of the three diseases. Assays for galactitol and galactose-1-phosphate and methods for assaying enzyme activities of GALT, GALK, and GALE are provided here. Interpretation of diagnostic results for screen-positive newborns or symptomatic patients, as well as therapeutic interventions based on biochemical phenotype and molecular genotype, are also included as decision trees.

Relationship between UDP-galactose 4'-epimerase activity and galactose sensitivity in yeast.

UDP-galactose 4'-epimerase (GALE) catalyzes the final step of the highly conserved Leloir pathway of galactose metabolism. Loss of GALE in humans results in a variant form of the metabolic disorder, galactosemia. Loss of GALE in yeast results in galactose-dependent growth arrest. Although the role of GALE in galactose metabolism has been recognized for decades, the precise relationship between GALE activity and galactose sensitivity has remained unclear. Here we have explored this relationship by asking the following. 1) Is GALE rate-limiting for galactose metabolism in yeast? 2) What is the relationship between GALE activity and galactose-dependent growth arrest in yeast? 3) What is the relationship between GALE activity and the abnormal accumulation of galactose metabolites in yeast? To answer these questions we engineered a strain of yeast in which GALE was doxycycline-repressible and studied these cells under conditions of intermediate GALE expression. Our results demonstrated a smooth linear relationship between galactose metabolism and GALE activity over a range from 0 to approximately 5% but a steep threshold relationship between growth rate in galactose and GALE activity over the same range. The relationship between abnormal accumulation of metabolites and GALE activity was also linear over the range from 0 to approximately 5%, suggesting that if the abnormal accumulation of metabolites underlies galactose-dependent growth-arrest in GALE-impaired yeast, either the impact of individual metabolites must be synergistic and/or the threshold of sensitivity must be very steep. Together these data reveal important points of similarity and contrast between the roles of GALE and galactose-1-phosphate uridylyltransferase in galactose metabolism in yeast and provide a framework for future studies in mammalian systems.

Brucella melitensis 16M: characterisation of the galE gene and mouse immunisation studies with a galE deficient mutant.

The galE gene of Streptomyces lividans was used to probe a cosmid library harbouring Brucella melitensis 16M DNA and the nucleotide sequence of a 2.5 kb ClaI fragment which hybridised was determined. An open reading frame encoding a predicted polypeptide with significant homology to UDP-galactose-4-epimerases of Brucella arbortus strain 2308 and other bacterial species was identified. DNA sequences flanking the B. melitensis galE gene shared no identity with other gal genes and, as for B. abortus, were located adjacent to a mazG homologue. A plasmid which encoded the B. melitensis galE open reading frame complemented a galE mutation in Salmonella typhimurium LB5010, as shown by the restoration of smooth lipopolysaccharide (LPS) biosynthesis, sensitivity to phage P22 infection and restoration of UDP-galactose-4-epimerase activity. The galE gene on the B. melitensis 16M chromosome was disrupted by insertional inactivation and these mutants lacked UDP-galactose-4-epimerase activity but no discernible differences in LPS structure between parent and the mutants were observed. One B. melitensis 16M galE mutant, Bm92, was assessed for virulence in CD-1 and BALB/c mice and displayed similar kinetics of invasion and persistence in tissues compared with the parent bacterial strain. CD-1 mice immunised with B. melitensis 16M galE were protected against B. melitensis 16M challenge.

Relationship between UDP-glucose 4-epimerase activity and oligoglucose glycoforms in two strains of Neisseria meningitidis.

Sodium dodecyl sulfate-polyacrylamide gel analysis of lipooligosaccharide (LOS) from Neisseria meningitidis has demonstrated considerable microheterogeneity in the variable region of LOS due to the presence of novel glycoforms. As a step toward understanding the basis for the expression of these novel glycoforms, we have examined the LOS structures and UDP-glucose 4-epimerase (epimerase) activity levels in two strains (NMB and MA-1) and their respective galE mutants. Strain NMB was found to have low epimerase activity and to contain multiple glycoforms, some of which appear to contain only glucose sugars. The galE mutant had only the oligoglucose glycoforms. Strain MA-1 had higher epimerase activity at both log and stationary phases (2- and 12.5-fold, respectively) and one glycoform with a putative lactosyl structure. Strain MA-1 galE had two glycoforms that contained one or two glucose residues. To understand the molecular basis for the different epimerase activities, we examined the predicted amino acid sequences of the respective galE open reading frames and determined the relative amounts of GalE protein. We found no significant differences between the predicted amino acid sequence of the GalE protein in NMB and that in MA-1. We observed no significant differences in the level of GalE protein between MA-1 and NMB at exponential or stationary phase. We also observed an 8.2-fold drop in epimerase activity in NMB between the log and stationary phases that was not due to the GalE protein level or low glucose levels.

Chondrolysis associated with cartilage canals of the epiphyseal cartilage of the distal humerus of growing pigs.

The articular-epiphyseal (A-E) cartilage of the distal humeri of 7 pigs weighing 13.1 to 18.2 kg and of 3 pigs weighing 36.4 to 40.9 kg was studied. Frozen samples of A-E cartilage were stained for the presence of reduced nicotinamide adenine dinucleotide dehydrogenase, lactate dehydrogenase, isocitrate dehydrogenase, and uridine diphosphate galactose-4-epimerase. Additional frozen sections and paraffin-processed sections were stained using the Alcian blue-critical electrolyte concentration method, safranin O-fast green, and hematoxylin and eosin. An area of grossly visible, opaque A-E cartilage of the medial condyle corresponded to regions of chondrolysis of the epiphyseal cartilage. The chondrolytic regions contained chondrocytes that did not stain for enzymes, had reduced staining for proteoglycans in the matrix, and were located at the site where the A-E cartilage increased in thickness. Cartilage canals were associated with the chondrolytic areas. Cartilage canals in both groups of pigs were commonly in various stages of chondrification, some of which were associated with degenerative cartilage. The regions of chondrolysis may indicate sites of biomechanical weakness in the A-E cartilage during the transformation of the epiphyseal cartilage into bone.

Further observations in a case of uridine diphosphate galactose-4-epimerase deficiency with a severe clinical presentation.

The red-cell concentrations of galactose-1-phosphate and uridine diphosphate galactose have been studied in relation to dietary galactose in a case of uridine diphosphate galactose-4-epimerase deficiency (McKusick 23035). Uridine diphosphate galactose accumulates rapidly in response to very small amounts of galactose but the concentration of galactose-1-phosphate increases proportionately to galactose intake. The significance of the observation is discussed with respect to the pathogenesis and treatment of the disease.

[Histochemical demonstration of uridine diphospho-glucoso-4'-epimerase activity]. / Dimostrazione istochimica dell'attivita' dell'uridin difosfo glucoso 4' - epimerasi

In the byosinthesis of glycosaminoglycans, UDP-glucose is utilized by two enzymes: UDP-glucose dehydrogenase which produces UDP-glucuronic acid (chondroitin sulphate precursor), and UDP-glucose 4'-epimerase which produces UDP-galactose (keratan sulphate precursor). The mechanisms regulating these two reactions have particular interest mainly considering that many connective tissues can modify its glycosaminoglycan production with aging; it is well-known that cartilage of young animals synthesizes almost exclusively chondroitin sulphate while cartilage of old animals synthesizes both chrondroitin sulphate and keratan sulphate. The kinetic parameters of both enzymes utilizing UDP-glucose have been recently investigated and some mechanisms responsible for UDP-glucose utilization in glycosaminoglycan biosynthesis have been evidenced. Under histoenzymological viewpoint, we have confirmed the inhibiting effect of UDP-xilose on UDP-glucose dehydrogenase and the possible role of such nucleotide in aging processes of cartilage. In order to study this problem even by a histoenzymological approach, an original method for histochemical determination of UDP-glucose 4'-epimerase activity in connective tissue cells was developed. This method seem to be more sensitive than that described by other authors. In standard conditions the sections of the frozen tissue were incubated in Tris-HCL buffer, pH 8.8 (Tris concentration 0.025 M), containing 0.5 mM UDP-galactose, 2 mM NAD, 0.6mM NBT and an excess of UDP-glucose dehydrogenase (about 300 mU). Control experiments in the absence of UDP-galactose, UDP-glucose dehydrogenase and in the absence of both UDP-galactose an- UDP-glucose dehydrogenase were also carried out. Under our experimental conditions, UDP-glucose 4'-epimerase present in the cells epimerizes UDP-galactose (added in the incubation mixture) to UDP-glucose which can bo oxidized by the excess of UDP-glucose dehydrogenase to UDP-glucuronic acid with a consequent NADH formation. The NADH formed is able to reduce and precipitate NBT. As a control of experimental sistem, we have determined the increase in O.D. at 525 nm of a reaction solution that was incubated directly in the spectrophotometer cuvette, at 37 degrees C with UDP-galactose 0.2 mM, NAD 2 mM, NBT 0.6 mM, 200 mU of UDP-glucose, dehydrogenase, 400mU of UDP-glucose 4'-epimerase and Tris HCL buffer pH 8.8 to a final volume of 1 ml. Histoenzymological and biochemical results demonstrate that this method is specific for and sensitive to UDP-glucose 4'-epimerase activity.

The first enzyme of the gal operon in inducible and operator-constitutive strains of Escherichia coli. A comparison of the porperties and amino-terminal sequences of UDP galactose 4-epimerase.

1. UDPgalactose 4-epimerase, the product of the first structural gene of the gal operon in Escherichia coli K-12, has been purified from strain HfrH and from its gal operator-constitutive mutant, HfrH 81-2. 2. The two enzymes are purified by the same procedure, behaving identically throughout. They are identical in sedimentation coefficient, sioelectric point, electrophoretic mobility at pH 8.8 and amino-terminal sequence for the first 30 residues. 3. Slight but reporducible differences were observed between the amino acid compositions and peptide maps of the two proteins. These differences may indicate real differences in the primary sequences of the proteins, but if so they are unlikely to be due to the operator-constitutive mutation because of the identy of the sequences for the first 30 residues. 4. No evidence was found to indicate that the gal operator might overlap with the first structural gene.